Parsippany, NJ, United States of America

Naveen Palwai

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Naveen Palwai: Pioneering Advances in Abaloparatide Research

Introduction

Naveen Palwai is an accomplished inventor based in Parsippany, NJ, USA. With a remarkable portfolio of four patents, he has made significant contributions to the field of pharmaceutical innovation, particularly focusing on abaloparatide.

Latest Patents

Naveen Palwai's latest patents include innovative formulations and methods related to abaloparatide. These patents describe newly discovered methods of analyzing abaloparatide samples for specific isomers. Furthermore, the patents detail methods of storing and treating with abaloparatide considering the newly identified isomers, reflecting a deep understanding of the compound's chemistry and potential applications.

Career Highlights

Currently, Naveen is associated with Radius Health, Inc., where he employs his expertise in advancing drug development and formulation techniques. His work has been pivotal in the efforts to enhance the safety and efficacy of abaloparatide, contributing to progress in therapeutics for bone health.

Collaborations

Throughout his career, Naveen has collaborated with notable professionals like Greg Williams and David Hanley. These partnerships have fostered an environment of innovation and shared knowledge within the research team, ultimately leading to the groundbreaking patents he holds today.

Conclusion

In conclusion, Naveen Palwai stands out as a prominent inventor in the realm of abaloparatide research. His innovative approaches and collaborative spirit continue to shape the future of pharmaceutical science, ensuring significant advancements in patient care and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…